Insider Transactions in Q4 2021 at Pardes Biosciences, Inc. (PRDS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Deepika Pakianathan Director |
BUY
Conversion of derivative security
|
Direct |
52,500
+50.0%
|
-
|
|
Dec 23
2021
|
Fs Development Holdings Ii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,873,750
+50.0%
|
-
|
|
Dec 23
2021
|
Owen Hughes Director |
BUY
Conversion of derivative security
|
Direct |
52,500
+50.0%
|
-
|
|
Dec 23
2021
|
Daniel Dubin Director |
BUY
Conversion of derivative security
|
Direct |
52,500
+50.0%
|
-
|
|
Dec 23
2021
|
James B. Tananbaum President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
8,759,072
+50.0%
|
$43,795,360
$5.0 P/Share
|
|
Dec 23
2021
|
James B. Tananbaum President and CEO |
BUY
Conversion of derivative security
|
Indirect |
4,873,750
+50.0%
|
-
|
|
Dec 22
2021
|
James B. Tananbaum President and CEO |
BUY
Open market or private purchase
|
Indirect |
325,000
+50.0%
|
$3,250,000
$10.0 P/Share
|